This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
This is a non-interventional study to evaluate the distribution of human leukocyte antigen (HLA)-DRB1\*04:01 genotype in participants that are recently (within 6 months of the study visit) diagnosed with T1D, with a single blood draw for the analysis of HLA genotype within the study participants. Some participants may elect to collect buccal cells via cheek swabs for genotype analysis. The study duration will be approximately 24 hours and will include a single study visit for the collection of demographic data and a single blood draw or cheek swab, and a follow-up telephone call approximately 24 hours after the study visit.
Study Type
OBSERVATIONAL
Enrollment
200
a blood draw or cheek swab for testing of HLA-DRB1\*04:01
University of California, San Francisco
San Francisco, California, United States
RECRUITINGUniversity of Florida- Gainesville
Gainesville, Florida, United States
RECRUITINGJoslin Diabetes Center
Boston, Massachusetts, United States
HLA DRB1*04:01 positive
to evaluate the frequency of adults with recently diagnosed type 1 diabetes that are HLA DRB1\*04:01 positive at time of enrollment
Time frame: Day 1
HLA-DRB1*04:01 genotype by ethnic and racial subgroups
to determine the distribution of HLA-DRB1\*04:01 genotype in adults recently diagnosed with type 1 diabetes at the time of enrollment by ethnic and racial subgroups
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
RECRUITINGUniversity of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
RECRUITING